Adarza BioSystems, Inc.
Adarza has developed a revolutionary label-free, microarray immunoassay platform for measuring biomarkers in research and clinical samples.
Adarza is developing a next generation multiplex immunoassay platform that overcomes the multiplex, workflow, and throughput limitations of current products. Adarza will meet or exceed current gold standard performance levels with a label-free platform that substantially reduces the number of process steps. No research or diagnostic product currently exists that can achieve this level of multiplexing while maintaining high sensitivity.